Novel SARS-CoV-2 vaccine program 04/07/2020 Avidin´s novel SARS-CoV-2 vaccine program has been funded by National Research, Development and Innovation Office Project identification number: 2020-2.1.1.-ED-2020-00015Project title:
Avidin together with partner Synaptogenex awarded with Market-leaded Research Development and Innovation Support 20.01.2020 Project title: Development, testing and production of active compounds and functional
In the last decade, oxidative stress has emerged as a key factor in many diseases including cardiovascular diseases, cancer, atherosclerosis, diabetes, arthritis, lung, kidney, liver disease, neurodegenerative disorders, and neuropathy.
Genetic predisposition and life style management contribute to the development of type 2 diabetes mellitus (T2DM).
PHC-14-2015 „Novel therapeutic approaches for the treatment of cystic fibrosis based on small molecule transmembrane anion…
FP7 grant “XENOISLET” Project full title: “Macroencapsulated Porcine Pancreatic Islets to cure Diabetes Mellitus type 1/2”…